Clinical Trial Update: Repeatability of Positron Emission Tomography (TEP) With fluorométhyl-(18F)-diméthyl-2-hydroxyéthyl-ammonium [NA]

View source ↗

Summary

A completed clinical trial evaluated the repeatability of PET imaging using the radiotracer fluoromethyl-(18F)-dimethyl-2-hydroxyethyl-ammonium in prostate canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Poitiers University Hospital | Conditions: Prostate Cancer | NA | Status: COMPLETED